Riccardo Scarin

Riccardo obtained a Master Degree in Pharmaceutical Biotechnology at University of Padua. He is currently doing a PhD in Atlas Molecular Pharma, focusing on the characterization of ligand-protein interaction with the aim of developing a Pharmacological Chaperon for the treatment of Tyrosinemia type I.